$
231.25
Apr 25
Business Description
Medifast Inc
NAICS : 812199
SIC : 7299
ISIN : US58470H1014
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.82 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 0.16 | |||||
Interest Coverage | 698.35 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 8.15 | |||||
Beneish M-Score | -3.4 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.6 | |||||
3-Year EBITDA Growth Rate | 3 | |||||
3-Year EPS without NRI Growth Rate | 1.8 | |||||
3-Year FCF Growth Rate | 3.2 | |||||
3-Year Book Growth Rate | 11.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.43 | |||||
Quick Ratio | 1.84 | |||||
Cash Ratio | 1.63 | |||||
Days Inventory | 97.96 | |||||
Days Payable | 102.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 3.1 | |||||
3-Year Average Share Buyback Ratio | 2.5 | |||||
Shareholder Yield % | 20.04 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.37 | |||||
Operating Margin % | 11.79 | |||||
Net Margin % | 9.27 | |||||
FCF Margin % | 13.17 | |||||
ROE % | 54.86 | |||||
ROA % | 31.33 | |||||
ROIC % | 99.13 | |||||
ROC (Joel Greenblatt) % | 177.49 | |||||
ROCE % | 63.42 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 3.7 | |||||
PE Ratio without NRI | 3.47 | |||||
Shiller PE Ratio | 4.8 | |||||
Price-to-Owner-Earnings | 2.99 | |||||
PEG Ratio | 0.17 | |||||
PS Ratio | 0.34 | |||||
PB Ratio | 1.81 | |||||
Price-to-Tangible-Book | 1.81 | |||||
Price-to-Free-Cash-Flow | 2.59 | |||||
Price-to-Operating-Cash-Flow | 2.48 | |||||
EV-to-EBIT | 1.87 | |||||
EV-to-EBITDA | 1.7 | |||||
EV-to-Revenue | 0.22 | |||||
EV-to-FCF | 1.68 | |||||
Price-to-Projected-FCF | 0.21 | |||||
Price-to-DCF (Earnings Based) | 0.77 | |||||
Price-to-DCF (FCF Based) | 0.57 | |||||
Price-to-Median-PS-Value | 0.21 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.14 | |||||
Price-to-Graham-Number | 0.53 | |||||
Price-to-Net-Current-Asset-Value | 3.16 | |||||
Price-to-Net-Cash | 8.77 | |||||
Earnings Yield (Greenblatt) % | 53.48 | |||||
FCF Yield % | 38.68 | |||||
Forward Rate of Return (Yacktman) % | 50.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medifast Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,072.055 | ||
EPS (TTM) ($) | 9.06 | ||
Beta | -0.16 | ||
Volatility % | 0.96 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 231.25 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 231.25 - 231.25 | ||
Shares Outstanding (Mil) | 10.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medifast Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medifast Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Medifast Inc Frequently Asked Questions
What is Medifast Inc(LTS:0K05)'s stock price today?
When is next earnings date of Medifast Inc(LTS:0K05)?
Does Medifast Inc(LTS:0K05) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |